Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport

European Journal of Pharmaceutical Sciences

Volumn 12, Issue 4, 2001, Pages 525-543

  Hooiveld, Guido J E J ^a   Van Montfoort, Jessica E ^a,b   Meijer, Dirk K F ^a   Müller, Michael ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

ATP binding cassette transport protein; Bile formation; Cholestasis; Liver; Regulation; Review

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; BILE SALT; CARRIER PROTEIN; CHOLESTEROL; CIPROFIBRATE; CLOFIBRATE; CYCLOHEXIMIDE; CYTOKINE; ENDOTHELIN RECEPTOR; ETOPOSIDE; GLUTATHIONE; GLYCOPROTEIN P; LEUKOTRIENE C4; MEMBRANE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; PEROXISOME PROLIFERATOR; REACTIVE OXYGEN METABOLITE; RETINOIC ACID; RETINOIC ACID RECEPTOR; SIMVASTATIN; STEROID; STEROL REGULATORY ELEMENT BINDING PROTEIN; TAUROCHOLIC ACID; TAUROLITHOCHOLIC ACID; TRANSCRIPTION FACTOR; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VINBLASTINE; VINCRISTINE;

BILE SECRETION; CHOLESTASIS; DRUG ELIMINATION; DRUG TRANSPORT; ENZYME SPECIFICITY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HEPATOBILIARY SYSTEM; HUMAN; LIVER CELL; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; TRANSCYTOSIS; TRANSPORT AT THE CELLULAR LEVEL; TRANSPORT KINETICS;

EID: 0035108792     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(01)00101-4     Document Type: Article

References (192)

1. Molecular characterization and tissue distribution of a new organic anion transporter subtype (oatp3) that transports thyroid hormones and taurocholate and comparison with oatp2
2. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1
3. Modulation of hepatic content and biliary excretion of P-glycoproteins in hepatocellular and obstructive cholestasis in the rat
4. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database
5. Effects of cytokines on the liver
6. MOAT-E (ARA) is a full-length MRP/cMOAT subfamily transporter expressed in kidney and liver
7. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
8. Hepatocyte transport of bile acids and organic anions in endotoxemic rats: Impaired uptake and secretion
9. The multidrug resistance protein family
10. What have we learnt thus far from mice with disrupted P-glycoprotein genes?
11. Genetic dissection of the function of mammalian P-glycoproteins
12. New physiological functions for drug-transporting P-glycoproteins?
13. i, cell volume, and bile secretion
14. The ABCA subclass of mammalian transporters
15. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
16. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor
17. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood
18. Cloning and regulation of the rat mdr2 gene
19. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes
20. mdr2 encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies
21. The inability of the mouse mdr2 gene to confer multidrug resistance is linked to reduced drug binding to the protein
22. cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats
23. Enhancement of mdr2 gene transcription mediates the biliary transfer of phosphatidylcholine supplied by an increased biosynthesis in the pravastatin-treated rat
24. Effect of multidrug resistance-reversing agents on transporting activity of human canalicular multispecific organic anion transporter
25. Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse
26. Identification of a sister gene to P-glycoprotein
27. Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein
28. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells
29. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
30. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues
31. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells
32. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
33. Complete inventory of the yeast ABC proteins
34. Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis
35. +-independent organic anion transporting polypeptide (oatp-l) in rats with bile duct ligation
36. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA
37. Basolateral localization and export activity of the human multidrug resistance-associated protein (MRP) in polarized pig kidney cells
38. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas
39. Influence of bile salts on hepatic mdr2 P-glycoprotein expression
40. Regulation of mdr2 P-glycoprotein expression by bile salts
41. Human MRP3 transporter: identification of the 5′-flanking region, genomic organization and alternative splice variants
42. Context-dependent transcriptional regulation
43. Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver
44. Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver
45. The sister of P-glycoprotein represents the canalicular bile salt export pump of mammalian liver
46. Orphan nuclear receptors: from gene to function
47. Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea in human glioma cells
48. Cloning and characterization of two human polyspecific organic cation transporters
49. Biochemistry of multidrug resistance mediated by the multidrug transporter
50. Regulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents
51. Molecular cloning and characterization of the murine bile salt export pump
52. Drug excretion mediated by a new prototype of polyspecific transporter
53. Molecular properties of hepatic uptake systems for bile acids and organic anions
54. +/bile acid cotransporter
55. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes
56. +/bile acid cotransport system
57. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides
58. ABC Transporters - From Microorganisms to Man
59. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in Eisai hyperbilirubinemic rats
60. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3)
61. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3)
62. Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor α in primary rat hepatocyte cultures
63. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats
64. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters
65. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1
66. Coordinated induction of MRP/GS-X pump and gamma-glutamylcysteine synthetase by heavy metals in human leukemia cells
67. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR
68. +-independent organic anion transporter
69. Selective hepatobiliary transport defect for organic anions and neutral steroids in mutant rats with hereditary-conjugated hyperbilirubinemia
70. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis
71. Differential expression of multidrug resistance (mdr) and canalicular multispecific organic anion transporter (cMOAT) genes following extrahepatic biliary obstruction in rats
72. Molecular characterization and functional regulation of a novel rat liver-specific organic anion transporter rlst-1
73. Identification and characterization of a prostaglandin transporter
74. Absense of the canalicular isoform of the MRP gene-encoded conjugate export pump from the hepatocytes in Dubin-Johnson syndrome
75. Induction of hepatic mrp2 (cMrp/cMoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen
76. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes
77. Sequence analysis and functional characterization of the 5′-flanking region of the rat multidrug resistance protein 2 (MRP2) gene
78. Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2)
79. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta
80. cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)
81. An inventory of the human ABC proteins
82. Organic cation transporters in intestine, kidney, liver, and brain
83. Molecular pharmacology of organic cation transporters in kidney
84. The direct activation of human multidrug resistance gene (Mdr1) by anticancer agents
85. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene
86. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines
87. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells
88. MRP3, an organic anion transporter able to transport anti-cancer drugs
89. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat
90. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
91. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
92. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane
93. Regulation of the multidrug resistance protein 2 in the rat liver by lipopolysaccharide and dexamethasone
94. Regulation of organic anion and drug transporters of the sinusoidal membrane
95. Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver
96. Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: a molecular example of the convergence theory of hepatocarcinogenesis?
97. Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues
98. Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers
99. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain
100. Cloning and expression of murine sister of P-glycoprotein reveals a more discriminating transporter than MDR1/P-glycoprotein
101. Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
102. Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter
103. 4 as a substrate for oatp1, the hepatic sinusoidal organic solute transporter
104. Characterization of vincristine transport by the M-r 190 000 multidrug resistance protein (MRP): Evidence for cotransport with reduced glutathione
105. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione
106. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT)
107. Regulation of hepatic glutathione synthesis: current concepts and controversies
108. Identification of 5′ and 3′ sequences involved in the regulation of transcription of the human md1 gene in vivo
109. Transport function and hepatocellular localization of mrp6 in rat liver
110. Cloning and functional characterization of a new multispecific organic anion transporter, OAT-K2, in rat kidney
111. pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells
112. 12-O-tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1
113. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver
114. Hepatobiliary disposition and targeting of drugs and genes
115. Hepatobiliary elimination of cationic drugs: the role of P-glycoproteins and other ATP-dependent transporters
116. Overexpression of mdr2 gene by peroxisome proliferators in the mouse liver
117. Activation of human multidrug resistance-1 gene promoter in response to heat shock stress
118. Effect of endotoxin on bile acid transport in rat liver: A potential model for sepsis-associated cholestasis
119. Molecular aspects of hepatobiliary transport
120. The secretory function of the liver: new aspects of hepatobiliary transport
121. A reevaluation of substrate specificity of the rat cation transporter rOCT1
122. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachioride intoxication
123. Mechanisms and regulation of bile secretion
124. Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
125. Characterization of inducible nature of MRP3 in rat liver
126. Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs
127. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene
128. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2
129. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte
130. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
131. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene
132. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome
133. ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1
134. Glutathione S-conjugate transport in hepatocytes entering the cell cycle is preserved by a switch in expression from the apical MRP2 to the basolateral MRP1 transporting protein
135. Impaired hepatocanalicular organic anion transport in endotoxemic rats
136. Increased levels of the multidrug resistance protein in lateral membranes of proliferating hepatocyte-derived cells
137. Phosphatidylcholine translocase: A physiological role for the mdr2 gene
138. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
139. Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney
140. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
141. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
142. Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
143. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
144. Expression cloning and characterization of a novel multispecific organic anion transporter
145. Hepatic canalicular membrane. 4. Expression of the multidrug resistance genes in the liver
146. Characterization of the promoter region of the human MDR3 P-glycoprotein gene
147. Tissue distribution of the human MDR3 P-glycoprotein
148. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
149. Contribution of the murine mdr1a P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdr1a gene disruption
150. Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disrupted
151. Hepatocyte-specific expression of the human MDR3 P-glycoprotein gene restores the biliary phosphatidylcholine excretion absent in MDR2 (-/-) mice
152. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
153. Endotoxin-stimulated macrophages decrease bile acid uptake in WIF-B cells, a rat hepatoma hybrid cell line
154. DNA elements recognizing NF-Y and Sp1 regulate the human multidrug-resistance gene promoter
155. Detailed structural analysis on both human MRP5 and mouse mrps transcripts
156. Expression cloning and characterization of ROAT1
157. Biliary excretion of bile acid conjugates in a hyperbilirubinemic mutant Sprague-Dawley rat
158. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1
159. The human multidrug resistance protein 2 gene: functional characterization of the 5′-flanking region and expression in hepatic cells
160. Overexpression of the multidrug resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas
161. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis
162. Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues
163. Sp1 and egr-1 have opposing effects on the regulation of the rat Pgp2/mdr1b gene
164. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents
165. Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome
166. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors
167. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis
168. Exon-intron organization of the human multidrug-resistance protein 2 (MRP2) gene mutated in Dubin-Johnson syndrome
169. Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation
170. Isolation and sequence of the promoter region of the human multidrug-resistance (P-glycoprotein) gene
171. Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells
172. The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver
173. Sequence of mdr3 cDNA encoding a human P-glycoprotein
174. Polyspecific organic anion transporting polypeptides mediate hepatic uptake of amphipatic type II organic cations
175. Up-regulation of the multidrug resistance genes, mrp1 and mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver
176. Regulation of hepatic transport systems involved in bile secretion during liver regeneration in rats
177. Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome
178. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53
179. Endogenous glutathione conjugates: occurrence and biological functions
180. Tumor necrosis factor-α decreases hepatocyte bile salt uptake and mediates endotoxin-induced cholestasis
181. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein
182. Nuclear orphan receptors: the search for novel ligands and signaling pathways
183. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family
184. Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress
185. Localization of sequences that influence basal and cell type-specific activity of the murine mdr2 promoter
186. The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions
187. Cloning and functional expression of a human liver organic cation transporter
188. NF-κ B-mediated induction of mdr1b expression by insulin in rat hepatoma cells
189. Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin
190. Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriamycin
191. Evidence that SP1 modulates transcriptional activity of the multidrug resistance-associated protein gene
192. Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte cultures